These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34319962)

  • 1. 18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma.
    Erol Fenercioğlu Ö; Beyhan E; Ergül N; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Feb; 47(2):e144-e146. PubMed ID: 34319962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
    Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
    Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
    Gündoğan C; Kömek H; Can C; Yildirim ÖA; Kaplan İ; Erdur E; Poyraz K; Güzel Y; Oruç Z; Çakabay B
    Nucl Med Commun; 2022 Jan; 43(1):64-72. PubMed ID: 34661379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma.
    Tatar G; Beyhan E; Erol Fenercioğlu Ö; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Sep; 47(9):e596-e599. PubMed ID: 35930714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
    Xie F; Fu L; Zhou W
    Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
    Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
    Cheng Z; Zou S; Cheng S; Song S; Zhu X
    Clin Nucl Med; 2021 Sep; 46(9):764-765. PubMed ID: 34132674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.
    Deng M; Chen Y; Cai L
    Clin Nucl Med; 2021 Jul; 46(7):589-591. PubMed ID: 33630809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule.
    Chen H; Pang Y; Meng T; Yu X; Sun L
    Clin Nucl Med; 2021 May; 46(5):424-426. PubMed ID: 33782300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis.
    Wu S; Pang Y; Zhao L; Zhao L; Chen H
    Clin Nucl Med; 2021 Oct; 46(10):847-849. PubMed ID: 34028415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis.
    Zheng J; Lin K; Zheng S; Yao S; Miao W
    Clin Nucl Med; 2022 Mar; 47(3):239-240. PubMed ID: 34619704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
    Zang J; Lin R; Wen X; Wang C; Zhao T; Jakobsson V; Yang Y; Wu X; Guo Z; Chen X; Zhang J; Miao W
    Clin Nucl Med; 2023 Oct; 48(10):861-868. PubMed ID: 37682601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.
    Fu H; Fu J; Huang J; Pang Y; Chen H
    Clin Nucl Med; 2021 Nov; 46(11):940-942. PubMed ID: 34034326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presacral Benign Schwannoma Mimics Malignancy on 18F-FDG and 68Ga-FAPI PET/CT.
    Zhu Y; Wu J; Wang Y; Geng J; Zhang C
    Clin Nucl Med; 2022 Mar; 47(3):277-278. PubMed ID: 34653050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor.
    Qiu L; Lan L; Liu H; Deng J; Chen Y
    Clin Nucl Med; 2022 Mar; 47(3):226-227. PubMed ID: 34392281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-FAPI-04 PET/CT Versus 18F-FDG PET/CT in Malignant Peritoneal Mesothelioma.
    Gündoğan C; Güzel Y; Kömek H; Etem H; Kaplan İ
    Clin Nucl Med; 2022 Feb; 47(2):e113-e115. PubMed ID: 34392282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.
    Wu J; Zhang S; Rao Z; Wang Y; Zhang C
    Clin Nucl Med; 2022 Jul; 47(7):629-631. PubMed ID: 35452009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT Findings of Abdominal Leiomyosarcoma.
    Güzel Y; Can C; Söğütçü N; Gündeş E; Gündoğan C
    Clin Nucl Med; 2021 Dec; 46(12):e594-e597. PubMed ID: 34735413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
    Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Arslan E; Çermik TF; Ergül N
    Nucl Med Commun; 2023 Oct; 44(10):896-899. PubMed ID: 37450605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.